| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
8e-10 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
8e-09 |
| mRNA |
BIX-01294 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-07 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-07 |
| mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
5e-07 |
| mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
6e-07 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
7e-07 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
8e-07 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
9e-07 |
| mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
9e-07 |